530057 — Vivanza Biosciences Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹70.80m
- IN₹172.07m
- IN₹1.16bn
Annual cashflow statement for Vivanza Biosciences, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
R2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 3.33 | 7.17 | 6.95 | -6.66 | 5.44 |
| Depreciation | |||||
| Non-Cash Items | 4.06 | 4.19 | 4.13 | 3.51 | 2.79 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 17.2 | -20.8 | 9.24 | -22 | -34.2 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 24.7 | -9.46 | 20.4 | -25 | -25.8 |
| Capital Expenditures | 0 | 0 | -0.375 | -0.079 | -1.24 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0 | 0 | 0 | — | — |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0 | 0 | -0.375 | -0.079 | -1.24 |
| Financing Cash Flow Items | -9.99 | -4.18 | -4.13 | -3.51 | -2.79 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -24.8 | 10.3 | -19.8 | 24.6 | 26.5 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.102 | 0.858 | 0.26 | -0.5 | -0.516 |